Patent ID: 9168264
Filing Date: 2015-10-27
Classification: A61K,A61P

Abstract:
1. A method for normalizing excessive menstrual bleeding in a human subject comprising administering to the subject in need thereof, a therapeutically effective dose of a progesterone receptor modulator selected from the group consisting of CDB 2914, mifepristone, asoprisnil, onapristone, org33628, tanaproget, and tanaproget-combo, or a metabolite of CDB 2914 selected from the group consisting of CDB-3877, CDB-3963, CDB-3236, and CDB-4183, wherein the subject is suffering from a benign gynecological disease selected from the group consisting of uterine fibroids, adenomyosis, or a combination thereof, and wherein the subject is treated with a vascular occlusion method or a thermal related treatment.